Reported compounded Lipo-C administration context (not medical advice) Item Route Commonly reported context Subcutaneous or intramuscular Item Volume per injection Commonly reported context About 0.51 mL, per the compounded label Item Frequency Commonly reported context Once or twice weekly (some plans 23x weekly) Item Example formula strength Commonly reported context Methionine/Inositol/Choline/L-Carnitine/B1/B5 at 15/50/50/50/15/5 mg/mL (Empower-style) Item Cycle framing Commonly reported context Used as an ongoing adjunct alongside diet and exercise Strengths and schedule vary by pharmacy
The variation it points to includes pain perception, inflammatory status, prior injection experience, tissue composition, and innervation density, along with subcutaneous fat thickness, skin hydration, and local blood flow
Metabolic changes included a reduction of the usage of muscle glycogen (i.e., its carbohydrate stores) during low-intensity exercise (consistent with an increase in lipid utilization) and streamlined glucose metabolism and mitochondrial flux during high-intensity exercise, leading to reduced anaerobic ATP production (which is what leads to lactic acid build-up in muscles)
Androgens regulate bone resorption and matrix deposition, positively correlating with bone mineral density
